NOREPINEPHRINE (BITARTRATE)

NOREPINEPHRINE (BITARTRATE) was reported 14748 times

NOREPINEPHRINE (BITARTRATE) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 293 0.7571
1 ANTACID THERAPY 93 0.7154
2 SLEEP DISORDER THERAPY 129 0.6515
3 ANALGESIC THERAPY 139 0.4330
4 DRUG THERAPY 134 0.3953
5 VITAMIN B1 INCREASED 15 0.3191
6 ANTICOAGULANT THERAPY 90 0.3169
7 SCHIZENCEPHALY 13 0.2889
8 CONGENITAL HIATUS HERNIA 64 0.2807
9 ELECTROCARDIOGRAM T WAVE ALTERNANS 12 0.2791
10 MALIGNANT MELANOMA STAGE 0 54 0.2584
11 MYOGLOBIN URINE PRESENT 60 0.2439
12 DIABETIC MACROANGIOPATHY 8 0.2424
13 CEREBRAL HAEMORRHAGE FOETAL 14 0.2295
14 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 16 0.1905
15 BLOOD LACTIC ACID DECREASED 32 0.1860
16 CARDIAC OUTPUT INCREASED 30 0.1754
17 MECHANICAL VENTILATION COMPLICATION 25 0.1678
18 COVID-19 TREATMENT 11 0.1618
19 BURKHOLDERIA TEST POSITIVE 20 0.1613
20 BACTEROIDES INFECTION 40 0.1533
21 MYOCARDIAL CALCIFICATION 17 0.1453
22 PROPOFOL INFUSION SYNDROME 99 0.1404
23 VITAMIN B1 DECREASED 34 0.1355
24 ELECTROCARDIOGRAM U WAVE PRESENT 8 0.1290
25 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 38 0.1092
26 INSPIRATORY CAPACITY DECREASED 25 0.0903
27 HYPERDYNAMIC LEFT VENTRICLE 22 0.0894
28 GENITAL EROSION 25 0.0842
29 HYPERPHOSPHATAEMIA 176 0.0818
30 CAFE AU LAIT SPOTS 8 0.0800
31 DRY GANGRENE 50 0.0787
32 VASOPLEGIA SYNDROME 127 0.0774
33 BLOOD PHOSPHORUS INCREASED 210 0.0768
34 MEAN ARTERIAL PRESSURE DECREASED 17 0.0672
35 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 59 0.0636
36 MYOCARDIAL STUNNING 8 0.0597
37 VASCULAR RESISTANCE SYSTEMIC DECREASED 8 0.0597
38 MYOGLOBINAEMIA 7 0.0593
39 CRUSH SYNDROME 8 0.0567
40 SPLENIC ABSCESS 20 0.0491
41 ACID BASE BALANCE ABNORMAL 11 0.0491
42 ANION GAP 31 0.0489
43 CARDIOGENIC SHOCK 683 0.0476
44 HYPERLACTACIDAEMIA 121 0.0451
45 PULMONARY HYPERTENSIVE CRISIS 12 0.0443
46 DISTRIBUTIVE SHOCK 97 0.0428
47 PHAEOCHROMOCYTOMA CRISIS 9 0.0425
48 MENINGOCOCCAL SEPSIS 8 0.0421
49 RENAL CORTICAL NECROSIS 9 0.0386
50 RESPIRATORY GAS EXCHANGE DISORDER 14 0.0377
51 GASTROINTESTINAL ISCHAEMIA 10 0.0361
52 MYOCARDIAL DEPRESSION 9 0.0349
53 CYTOTOXIC OEDEMA 9 0.0340
54 FOETAL EXPOSURE DURING DELIVERY 23 0.0339
55 TOTAL LUNG CAPACITY DECREASED 54 0.0338
56 EXTREMITY NECROSIS 59 0.0338
57 KIDNEY DUPLEX 8 0.0333
58 PHARYNGEAL HAEMORRHAGE 41 0.0333
59 ELECTROCARDIOGRAM P WAVE ABNORMAL 8 0.0327
60 NECROSIS ISCHAEMIC 15 0.0325
61 APPENDICITIS 300 0.0321
62 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 13 0.0320
63 ACETONAEMIA 8 0.0317
64 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 160 0.0316
65 MULTIPLE ORGAN DYSFUNCTION SYNDROME 891 0.0314
66 HAEMODYNAMIC INSTABILITY 238 0.0312
67 SYSTOLIC DYSFUNCTION 32 0.0304
68 PERIPHERAL ISCHAEMIA 124 0.0303
69 CSF PRESSURE INCREASED 8 0.0301
70 VENTRICULAR FIBRILLATION 334 0.0300
71 HEPATIC ISCHAEMIA 9 0.0289
72 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 10 0.0285
73 IRON DEFICIENCY 128 0.0284
74 LOCKED-IN SYNDROME 13 0.0282
75 BLOOD URIC ACID INCREASED 162 0.0280
76 DIABETES INSIPIDUS 65 0.0270
77 LARYNGOMALACIA 9 0.0269
78 STRESS CARDIOMYOPATHY 156 0.0268
79 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 9 0.0263
80 PULSELESS ELECTRICAL ACTIVITY 108 0.0258
81 DISSEMINATED MUCORMYCOSIS 10 0.0254
82 MUCOSAL EROSION 23 0.0253
83 VASOCONSTRICTION 22 0.0251
84 HYPOPHOSPHATAEMIA 185 0.0250
85 COMPARTMENT SYNDROME 65 0.0249
86 ISCHAEMIC HEPATITIS 34 0.0248
87 MATERNAL EXPOSURE DURING DELIVERY 24 0.0242
88 NECROTISING OESOPHAGITIS 12 0.0240
89 PNEUMONITIS ASPIRATION 8 0.0234
90 RHINOCEREBRAL MUCORMYCOSIS 8 0.0231
91 MYASTHENIA GRAVIS 185 0.0229
92 TROPONIN INCREASED 173 0.0227
93 BLINDNESS CORTICAL 11 0.0224
94 AORTIC STENOSIS 78 0.0224
95 ACUTE LUNG INJURY 26 0.0219
96 METHAEMOGLOBINAEMIA 50 0.0216
97 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 42 0.0213
98 LUNG OPACITY 56 0.0212
99 BRONCHOPULMONARY DYSPLASIA 17 0.0211
100 SHOCK 469 0.0204
101 ANION GAP INCREASED 27 0.0202
102 PNEUMONIA NECROTISING 13 0.0201
103 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 101 0.0197
104 MYOCARDIAL INJURY 22 0.0196
105 PLEURITIC PAIN 53 0.0192
106 PROCEDURAL HYPOTENSION 16 0.0188
107 VENTRICULAR HYPOKINESIA 60 0.0187
108 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 15 0.0182
109 SYSTEMIC CANDIDA 45 0.0179
110 LIMB AMPUTATION 7 0.0176
111 POOR SUCKING REFLEX 7 0.0176
112 INTESTINAL ISCHAEMIA 96 0.0174
113 EAR MALFORMATION 8 0.0173
114 ABDOMINAL COMPARTMENT SYNDROME 11 0.0173
115 HYPOPERFUSION 18 0.0171
116 BRASH SYNDROME 24 0.0171
117 AMYLASE INCREASED 63 0.0171
118 WOLFF-PARKINSON-WHITE SYNDROME 8 0.0169
119 HAEMOTHORAX 49 0.0169
120 SYMPTOM MASKED 12 0.0165
121 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 53 0.0160
122 DEVICE INFUSION ISSUE 39 0.0157
123 ACIDOSIS 120 0.0157
124 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 8 0.0157
125 TOXIC ENCEPHALOPATHY 79 0.0156
126 ACUTE RESPIRATORY DISTRESS SYNDROME 275 0.0155
127 ACINETOBACTER INFECTION 17 0.0155
128 NEONATAL ASPHYXIA 11 0.0155
129 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 34 0.0155
130 RESPIRATORY SYMPTOM 44 0.0155
131 HYPERTHERMIA MALIGNANT 23 0.0154
132 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 12 0.0154
133 TOXIC EPIDERMAL NECROLYSIS 230 0.0151
134 NON-CARDIOGENIC PULMONARY OEDEMA 16 0.0151
135 ANAL STENOSIS 8 0.0150
136 SEPSIS NEONATAL 12 0.0148
137 SERRATIA INFECTION 11 0.0148
138 RETINAL ISCHAEMIA 9 0.0147
139 INFANTILE APNOEA 12 0.0147
140 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 16 0.0145
141 DRUG EFFECT PROLONGED 8 0.0145
142 RESPIRATORY ACIDOSIS 57 0.0145
143 HEPARIN-INDUCED THROMBOCYTOPENIA 71 0.0144
144 CARDIOVASCULAR INSUFFICIENCY 23 0.0141
145 DELAYED GRAFT FUNCTION 10 0.0141
146 JARISCH-HERXHEIMER REACTION 10 0.0140
147 MECHANICAL ILEUS 8 0.0140
148 LABORATORY TEST INTERFERENCE 11 0.0140
149 MOTOR DEVELOPMENTAL DELAY 8 0.0138
150 APALLIC SYNDROME 10 0.0138
151 LEFT VENTRICULAR DILATATION 7 0.0137
152 METABOLIC ACIDOSIS 436 0.0136
153 SEPTIC SHOCK 591 0.0136
154 SPUTUM CULTURE POSITIVE 11 0.0135
155 RESPIRATORY TRACT HAEMORRHAGE 8 0.0134
156 ACUTE LEFT VENTRICULAR FAILURE 9 0.0134
157 OLIGURIA 83 0.0134
158 NEURODEVELOPMENTAL DISORDER 9 0.0133
159 BRAIN DEATH 41 0.0133
160 SUBCUTANEOUS EMPHYSEMA 13 0.0132
161 FUNGAL SEPSIS 11 0.0132
162 APGAR SCORE LOW 17 0.0132
163 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 14 0.0132
164 ENTEROCOCCAL SEPSIS 10 0.0123
165 CONTINUOUS HAEMODIAFILTRATION 12 0.0123
166 PHIMOSIS 9 0.0122
167 ARTERIOSPASM CORONARY 49 0.0122
168 BLOOD MAGNESIUM INCREASED 11 0.0122
169 DYSBIOSIS 10 0.0122
170 ANURIA 104 0.0121
171 VENTRICULAR TACHYCARDIA 199 0.0120
172 CLOSTRIDIUM TEST POSITIVE 26 0.0118
173 VENTRICULAR ARRHYTHMIA 43 0.0117
174 ASCITES 344 0.0117
175 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 30 0.0114
176 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 30 0.0113
177 BREATH SOUNDS ABNORMAL 55 0.0111
178 BACTERIAL INFECTION 207 0.0111
179 COMA SCALE ABNORMAL 32 0.0110
180 HYPERCHLORAEMIA 7 0.0109
181 BLOOD CALCIUM INCREASED 96 0.0109
182 NODAL RHYTHM 16 0.0109
183 PULSE ABSENT 52 0.0109
184 LACTIC ACIDOSIS 354 0.0109
185 ISCHAEMIA 50 0.0109
186 BENIGN PROSTATIC HYPERPLASIA 56 0.0108
187 EMBOLISM ARTERIAL 13 0.0108
188 HYPERCAPNIA 32 0.0106
189 ATRIOVENTRICULAR BLOCK FIRST DEGREE 46 0.0106
190 NODAL ARRHYTHMIA 9 0.0105
191 MUCORMYCOSIS 27 0.0104
192 STENOTROPHOMONAS INFECTION 14 0.0103
193 CRITICAL ILLNESS 8 0.0103
194 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 176 0.0103
195 CYTOKINE STORM 7 0.0102
196 ABDOMINAL SEPSIS 9 0.0102
197 BEZOAR 14 0.0101
198 PULMONARY VALVE STENOSIS 8 0.0100
199 PERFORATION 8 0.0099
200 MUSCLE NECROSIS 9 0.0099
201 DILATED CARDIOMYOPATHY 10 0.0099
202 SHOCK HAEMORRHAGIC 80 0.0098
203 TORSADE DE POINTES 77 0.0098
204 COLOUR BLINDNESS 9 0.0098
205 KLEBSIELLA SEPSIS 11 0.0098
206 BRADYCARDIA FOETAL 8 0.0096
207 SEROTONIN SYNDROME 185 0.0096
208 DEVELOPMENTAL HIP DYSPLASIA 8 0.0096
209 GASTROINTESTINAL NECROSIS 28 0.0096
210 FUNGAEMIA 15 0.0095
211 DISSEMINATED INTRAVASCULAR COAGULATION 134 0.0095
212 PNEUMATOSIS INTESTINALIS 27 0.0095
213 CEREBELLAR INFARCTION 16 0.0095
214 MULTI-ORGAN FAILURE 162 0.0094
215 GANGRENE 56 0.0093
216 HYPERLIPIDAEMIA 111 0.0093
217 ESCHERICHIA TEST POSITIVE 11 0.0092
218 PERICARDIAL HAEMORRHAGE 20 0.0091
219 LIVEDO RETICULARIS 19 0.0091
220 CARDIAC OUTPUT DECREASED 8 0.0091
221 BLOOD LACTIC ACID INCREASED 47 0.0089
222 BLOOD FIBRINOGEN INCREASED 7 0.0089
223 PATENT DUCTUS ARTERIOSUS 35 0.0088
224 ANTICHOLINERGIC SYNDROME 14 0.0088
225 CIRCULATORY COLLAPSE 149 0.0087
226 PUPIL FIXED 15 0.0087
227 WRONG PRODUCT ADMINISTERED 58 0.0086
228 PROCALCITONIN INCREASED 10 0.0085
229 KLEBSIELLA INFECTION 43 0.0085
230 FANCONI SYNDROME 12 0.0085
231 DEVICE RELATED SEPSIS 17 0.0084
232 PYELOCALIECTASIS 8 0.0084
233 RASH MORBILLIFORM 23 0.0083
234 CARDIAC ARREST 684 0.0083
235 PNEUMONIA KLEBSIELLA 15 0.0082
236 METABOLIC ALKALOSIS 13 0.0081
237 ANTIPHOSPHOLIPID SYNDROME 13 0.0081
238 TACHYARRHYTHMIA 20 0.0080
239 RESPIRATORY DEPRESSION 97 0.0079
240 TROPONIN T INCREASED 10 0.0079
241 MYOGLOBIN BLOOD INCREASED 12 0.0078
242 CANDIDA SEPSIS 7 0.0078
243 BRADYPNOEA 21 0.0078
244 OPTIC NERVE INJURY 9 0.0078
245 BRUGADA SYNDROME 8 0.0077
246 HYPERVOLAEMIA 38 0.0077
247 CATHETER SITE HAEMORRHAGE 19 0.0076
248 END STAGE RENAL DISEASE 138 0.0076
249 RIGHT VENTRICULAR FAILURE 53 0.0076
250 ENTEROCOCCAL BACTERAEMIA 8 0.0075
251 PRODUCT CONTAMINATION MICROBIAL 9 0.0075
252 EXTRAVASATION 31 0.0075
253 HYPOVOLAEMIA 44 0.0075
254 HAEMATOMA MUSCLE 9 0.0075
255 KOUNIS SYNDROME 17 0.0075
256 STRONGYLOIDIASIS 12 0.0074
257 ASPIRATION 81 0.0074
258 OPTIC ATROPHY 12 0.0074
259 BRADYCARDIA 386 0.0073
260 CAPILLARY LEAK SYNDROME 15 0.0072
261 LOW BIRTH WEIGHT BABY 57 0.0072
262 DEVICE ALARM ISSUE 13 0.0072
263 CEREBRAL HAEMATOMA 24 0.0071
264 RENAL TUBULAR NECROSIS 70 0.0071
265 CRYPTORCHISM 8 0.0071
266 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 183 0.0071
267 SUPRAVENTRICULAR TACHYCARDIA 68 0.0071
268 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 42 0.0071
269 COAGULOPATHY 118 0.0071
270 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 55 0.0071
271 RESPIRATORY FAILURE 514 0.0070
272 NEURALGIA 171 0.0070
273 BRAIN HERNIATION 21 0.0070
274 HYPONATRAEMIA 396 0.0070
275 BLOOD PH DECREASED 12 0.0070
276 NECROSIS 39 0.0070
277 CEREBELLAR HAEMORRHAGE 10 0.0070
278 NEPHROGENIC DIABETES INSIPIDUS 8 0.0069
279 CARDIOMYOPATHY 102 0.0069
280 PSEUDOMONAL SEPSIS 12 0.0068
281 ANGIOPATHY 38 0.0068
282 VASODILATATION 17 0.0067
283 CARDIAC TAMPONADE 32 0.0067
284 HYPOTENSION 1343 0.0067
285 PNEUMOMEDIASTINUM 12 0.0066
286 SEPSIS 740 0.0066
287 BLOOD TEST ABNORMAL 93 0.0066
288 HYPOTHERMIA 67 0.0066
289 HYPOXIA 233 0.0066
290 MULTI-ORGAN DISORDER 13 0.0066
291 TROPONIN I INCREASED 11 0.0066
292 FOETAL DISTRESS SYNDROME 14 0.0066
293 ELECTROCARDIOGRAM QT PROLONGED 235 0.0065
294 BILIARY TRACT DISORDER 9 0.0065
295 CARDIOTOXICITY 58 0.0065
296 PNEUMOPERITONEUM 12 0.0065
297 RETROPERITONEAL HAEMORRHAGE 16 0.0065
298 LIVER ABSCESS 21 0.0065
299 CARDIAC DYSFUNCTION 24 0.0064
300 HYPERNATRAEMIA 32 0.0064
301 SINUS BRADYCARDIA 62 0.0064
302 HYPOTONIA NEONATAL 10 0.0064
303 MEGACOLON 10 0.0064
304 GOUT 114 0.0063
305 ULCER 101 0.0063
306 ACUTE RESPIRATORY FAILURE 122 0.0063
307 METABOLIC ENCEPHALOPATHY 19 0.0063
308 RHABDOMYOLYSIS 264 0.0063
309 SPLENIC INFARCTION 11 0.0063
310 PSEUDOMONAS INFECTION 54 0.0063
311 LONG QT SYNDROME 15 0.0063
312 RENAL INFARCT 9 0.0062
313 ENTEROCOCCAL INFECTION 30 0.0062
314 INTENTIONAL OVERDOSE 398 0.0062
315 DACRYOSTENOSIS ACQUIRED 8 0.0062
316 PULMONARY SEPSIS 9 0.0062
317 SKIN NECROSIS 32 0.0062
318 LEFT VENTRICULAR DYSFUNCTION 41 0.0061
319 ELECTROCARDIOGRAM ABNORMAL 48 0.0061
320 ACUTE KIDNEY INJURY 929 0.0061
321 BRONCHOPULMONARY ASPERGILLOSIS 47 0.0061
322 SYSTEMIC INFECTION 10 0.0060
323 PREMATURE DELIVERY 95 0.0060
324 SINUS TACHYCARDIA 84 0.0059
325 HYPERTRANSAMINASAEMIA 41 0.0059
326 RETROPERITONEAL HAEMATOMA 13 0.0059
327 BACTERIAL SEPSIS 19 0.0058
328 LEUKOCYTOSIS 103 0.0057
329 HYPERTHERMIA 43 0.0056
330 CHOLESTASIS 108 0.0056
331 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 7 0.0056
332 RESPIRATORY ALKALOSIS 9 0.0055
333 PULMONARY ARTERIAL PRESSURE INCREASED 9 0.0055
334 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 21 0.0055
335 ANGLE CLOSURE GLAUCOMA 14 0.0055
336 COMA 258 0.0054
337 PUPILLARY REFLEX IMPAIRED 10 0.0054
338 VENTRICULAR DYSFUNCTION 14 0.0054
339 PRODUCT PACKAGING CONFUSION 13 0.0053
340 ORTHOPNOEA 17 0.0053
341 MYOCLONIC EPILEPSY 8 0.0053
342 MECHANICAL VENTILATION 10 0.0053
343 AREFLEXIA 14 0.0052
344 FIXED ERUPTION 9 0.0052
345 TRANSAMINASES INCREASED 116 0.0052
346 HYPERKALAEMIA 182 0.0052
347 COLITIS ISCHAEMIC 35 0.0052
348 PULMONARY ALVEOLAR HAEMORRHAGE 29 0.0052
349 SINUS ARREST 8 0.0051
350 INTERMITTENT CLAUDICATION 8 0.0050
351 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0050
352 CARDIAC FAILURE ACUTE 33 0.0049
353 BUNDLE BRANCH BLOCK LEFT 21 0.0049
354 CARDIAC FAILURE CHRONIC 21 0.0049
355 DRUG LEVEL BELOW THERAPEUTIC 27 0.0049
356 TACHYPNOEA 66 0.0048
357 ANAPHYLACTIC SHOCK 125 0.0048
358 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 265 0.0048
359 RESUSCITATION 8 0.0048
360 ACUTE PULMONARY OEDEMA 27 0.0048
361 BLOOD LACTATE DEHYDROGENASE INCREASED 76 0.0048
362 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
363 CYTOKINE RELEASE SYNDROME 96 0.0048
364 FIBRIN D DIMER INCREASED 17 0.0048
365 MYOCARDIAL NECROSIS MARKER INCREASED 8 0.0048
366 HYPERCHOLESTEROLAEMIA 46 0.0048
367 HYPOPROTEINAEMIA 9 0.0047
368 HEPATORENAL SYNDROME 8 0.0047
369 DEVICE CONNECTION ISSUE 10 0.0047
370 BRAIN OEDEMA 59 0.0047
371 BLOOD CHLORIDE INCREASED 8 0.0046
372 HEPATIC CYTOLYSIS 59 0.0046
373 INTRA-ABDOMINAL HAEMORRHAGE 11 0.0046
374 HYPOVOLAEMIC SHOCK 22 0.0046
375 PREMATURE BABY 138 0.0046
376 PNEUMONIA STAPHYLOCOCCAL 9 0.0046
377 MICTURITION URGENCY 52 0.0045
378 TUMOUR LYSIS SYNDROME 40 0.0045
379 NECROTISING FASCIITIS 16 0.0045
380 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
381 NEONATAL RESPIRATORY DISTRESS SYNDROME 16 0.0045
382 ATRIAL FLUTTER 36 0.0045
383 ATRIOVENTRICULAR BLOCK COMPLETE 30 0.0045
384 RALES 26 0.0045
385 INCORRECT DRUG ADMINISTRATION RATE 19 0.0045
386 VENOOCCLUSIVE LIVER DISEASE 22 0.0045
387 FULL BLOOD COUNT ABNORMAL 47 0.0044
388 HYPERBILIRUBINAEMIA 46 0.0044
389 CLOSTRIDIAL INFECTION 15 0.0044
390 HEPATITIS FULMINANT 13 0.0044
391 STAPHYLOCOCCAL BACTERAEMIA 19 0.0044
392 TOXICITY TO VARIOUS AGENTS 737 0.0044
393 IMMUNE THROMBOCYTOPENIA 20 0.0044
394 CARDIOPULMONARY FAILURE 17 0.0044
395 ENCEPHALOPATHY 107 0.0044
396 BUNDLE BRANCH BLOCK RIGHT 20 0.0044
397 PANCREATITIS NECROTISING 10 0.0043
398 NEUROLOGICAL DECOMPENSATION 10 0.0043
399 BLOOD POTASSIUM INCREASED 70 0.0043
400 BACTERAEMIA 51 0.0043
401 ENDOTRACHEAL INTUBATION 12 0.0043
402 BRADYARRHYTHMIA 7 0.0043
403 JAUNDICE CHOLESTATIC 15 0.0042
404 FOETAL DEATH 22 0.0042
405 OXYGEN SATURATION ABNORMAL 12 0.0042
406 PULMONARY OEDEMA 188 0.0042
407 TACHYCARDIA 372 0.0042
408 CANDIDA INFECTION 70 0.0041
409 ATRIOVENTRICULAR BLOCK 32 0.0041
410 MYDRIASIS 53 0.0041
411 PNEUMOTHORAX 65 0.0041
412 LIVER FUNCTION TEST INCREASED 88 0.0041
413 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 39 0.0041
414 PNEUMONIA FUNGAL 16 0.0041
415 CLONUS 11 0.0040
416 HAEMOLYSIS 31 0.0040
417 GENERALISED TONIC-CLONIC SEIZURE 66 0.0040
418 PULMONARY HAEMORRHAGE 31 0.0040
419 PATHOGEN RESISTANCE 36 0.0039
420 VASCULAR STENT THROMBOSIS 8 0.0039
421 SEDATION COMPLICATION 10 0.0039
422 BRAIN NATRIURETIC PEPTIDE INCREASED 12 0.0039
423 ESCHERICHIA INFECTION 32 0.0039
424 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 202 0.0039
425 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 29 0.0039
426 HEART VALVE INCOMPETENCE 11 0.0038
427 INFLAMMATORY MARKER INCREASED 19 0.0038
428 HEPATIC FAILURE 114 0.0038
429 MYOCLONUS 45 0.0038
430 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8 0.0038
431 HYPERTRIGLYCERIDAEMIA 22 0.0038
432 ORGAN FAILURE 15 0.0037
433 BRAIN INJURY 37 0.0037
434 BLOOD CHOLESTEROL INCREASED 172 0.0037
435 CARDIO-RESPIRATORY ARREST 153 0.0037
436 TYPE IV HYPERSENSITIVITY REACTION 10 0.0036
437 STAPHYLOCOCCAL SEPSIS 18 0.0036
438 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 12 0.0036
439 MYOCARDIAL ISCHAEMIA 41 0.0036
440 HYPOALBUMINAEMIA 28 0.0036
441 ADRENOCORTICAL INSUFFICIENCY ACUTE 7 0.0036
442 ERYSIPELAS 18 0.0036
443 DEPRESSED LEVEL OF CONSCIOUSNESS 141 0.0036
444 STATUS EPILEPTICUS 40 0.0035
445 THERAPY NON-RESPONDER 159 0.0035
446 CELL DEATH 7 0.0035
447 ESCHERICHIA URINARY TRACT INFECTION 15 0.0035
448 GENERAL PHYSICAL HEALTH DETERIORATION 407 0.0035
449 ACUTE HEPATIC FAILURE 48 0.0035
450 PROTHROMBIN TIME PROLONGED 21 0.0035
451 BLOOD CREATININE INCREASED 229 0.0035
452 ASPERGILLUS INFECTION 23 0.0035
453 RESPIRATORY RATE DECREASED 11 0.0035
454 LEFT VENTRICULAR FAILURE 12 0.0035
455 CYTOMEGALOVIRUS COLITIS 8 0.0035
456 HAEMANGIOMA 8 0.0035
457 RASH MACULO-PAPULAR 77 0.0035
458 HEPATIC NECROSIS 13 0.0034
459 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
460 BRONCHIECTASIS 23 0.0034
461 TONGUE OEDEMA 13 0.0034
462 STRIDOR 10 0.0034
463 PNEUMONIA BACTERIAL 31 0.0034
464 RENAL FAILURE 448 0.0034
465 BLOOD CREATINE PHOSPHOKINASE INCREASED 96 0.0033
466 HAEMODIALYSIS 28 0.0033
467 ASPARTATE AMINOTRANSFERASE INCREASED 177 0.0033
468 NORMOCHROMIC NORMOCYTIC ANAEMIA 10 0.0033
469 MIXED LIVER INJURY 10 0.0033
470 SUSPECTED OFF LABEL USE 15 0.0033
471 URINE OUTPUT DECREASED 29 0.0033
472 PULMONARY HYPERTENSION 69 0.0033
473 COVID-19 PNEUMONIA 39 0.0033
474 ATRIOVENTRICULAR BLOCK SECOND DEGREE 10 0.0033
475 DRUG LEVEL ABOVE THERAPEUTIC 15 0.0033
476 MITRAL VALVE INCOMPETENCE 37 0.0033
477 PULMONARY CONGESTION 43 0.0033
478 ACUTE CORONARY SYNDROME 27 0.0033
479 ALANINE AMINOTRANSFERASE INCREASED 198 0.0032
480 PLEURAL EFFUSION 196 0.0032
481 ILEUS 40 0.0032
482 LUNG CONSOLIDATION 9 0.0032
483 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
484 ATELECTASIS 31 0.0032
485 MENTAL STATUS CHANGES 89 0.0032
486 GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0032
487 ABDOMINAL DISTENSION 331 0.0032
488 PRODUCT PACKAGING ISSUE 30 0.0032
489 RESPIRATORY DISTRESS 87 0.0031
490 OBSTRUCTIVE AIRWAYS DISORDER 35 0.0031
491 RENAL IMPAIRMENT 262 0.0031
492 BLOOD PRESSURE SYSTOLIC DECREASED 14 0.0031
493 RENAL INJURY 91 0.0031
494 POOR PERIPHERAL CIRCULATION 13 0.0030
495 NEPHROPATHY TOXIC 34 0.0030
496 EJECTION FRACTION DECREASED 47 0.0030
497 NEPHROGENIC ANAEMIA 14 0.0030
498 FEAR 81 0.0030
499 HEPATOTOXICITY 67 0.0030
500 PNEUMONIA ASPIRATION 75 0.0030
501 HYPERAMMONAEMIA 15 0.0030
502 VENTRICULAR EXTRASYSTOLES 31 0.0030
503 ESCHERICHIA BACTERAEMIA 7 0.0030
504 DRUG LEVEL INCREASED 49 0.0030
505 ILEUS PARALYTIC 13 0.0029
506 THROMBOCYTOPENIA 320 0.0029
507 CONDITION AGGRAVATED 868 0.0029
508 DELIRIUM 99 0.0028
509 SPUTUM DISCOLOURED 27 0.0028
510 PULMONARY EMBOLISM 270 0.0028
511 CARDIOVASCULAR DISORDER 72 0.0028
512 SMALL FOR DATES BABY 14 0.0028
513 BLOOD BILIRUBIN INCREASED 76 0.0028
514 PROCEDURAL HAEMORRHAGE 11 0.0028
515 NEUTROPENIC SEPSIS 20 0.0028
516 HAEMOLYTIC ANAEMIA 25 0.0028
517 SPEECH DISORDER DEVELOPMENTAL 8 0.0028
518 BLOOD PRESSURE DECREASED 185 0.0028
519 ALTERED STATE OF CONSCIOUSNESS 60 0.0028
520 ESCHERICHIA SEPSIS 8 0.0028
521 THROMBOSIS IN DEVICE 9 0.0027
522 PRODUCT LABEL CONFUSION 16 0.0027
523 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
524 THROMBOCYTOSIS 10 0.0027
525 DIABETES MELLITUS 208 0.0027
526 BLOOD CREATINE INCREASED 12 0.0027
527 HYPOTONIA 27 0.0027
528 THROMBOSIS 217 0.0027
529 INTENTIONAL PRODUCT MISUSE 234 0.0027
530 NERVOUS SYSTEM DISORDER 82 0.0026
531 AUTOIMMUNE HAEMOLYTIC ANAEMIA 9 0.0026
532 RENAL FAILURE ACUTE 111 0.0026
533 BLOOD SODIUM INCREASED 7 0.0026
534 DIASTOLIC DYSFUNCTION 8 0.0026
535 EMPHYSEMA 26 0.0026
536 JOINT INJURY 55 0.0026
537 EOSINOPHILIA 45 0.0026
538 UNRESPONSIVE TO STIMULI 66 0.0026
539 HYPOKALAEMIA 118 0.0026
540 AMMONIA INCREASED 13 0.0025
541 VENOUS THROMBOSIS 10 0.0025
542 HAEMOPTYSIS 71 0.0025
543 DRUG INTERACTION 401 0.0025
544 CEREBRAL ISCHAEMIA 13 0.0025
545 INFARCTION 17 0.0025
546 STEVENS-JOHNSON SYNDROME 55 0.0025
547 POSTURE ABNORMAL 8 0.0025
548 UPPER GASTROINTESTINAL HAEMORRHAGE 41 0.0024
549 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
550 DRY MOUTH 196 0.0024
551 ADVERSE REACTION 32 0.0024
552 BLOOD UREA INCREASED 40 0.0024
553 SUBARACHNOID HAEMORRHAGE 24 0.0024
554 CREPITATIONS 7 0.0023
555 CORONARY ARTERY DISEASE 71 0.0023
556 ENDOCARDITIS 12 0.0023
557 BLOOD CULTURE POSITIVE 7 0.0023
558 INTRACRANIAL PRESSURE INCREASED 13 0.0023
559 POLYURIA 19 0.0023
560 HYPERGLYCAEMIA 84 0.0023
561 HYPERREFLEXIA 8 0.0023
562 CHOLECYSTITIS ACUTE 13 0.0023
563 FOETAL EXPOSURE DURING PREGNANCY 186 0.0023
564 NYSTAGMUS 12 0.0023
565 SUICIDE ATTEMPT 137 0.0023
566 MULTIPLE-DRUG RESISTANCE 7 0.0023
567 AZOTAEMIA 9 0.0023
568 DRUG INEFFECTIVE 2961 0.0022
569 ANAPHYLACTIC REACTION 124 0.0022
570 POST PROCEDURAL HAEMORRHAGE 26 0.0022
571 ADRENAL INSUFFICIENCY 27 0.0022
572 EOSINOPHILIC PNEUMONIA 7 0.0022
573 MATERNAL EXPOSURE DURING BREAST FEEDING 9 0.0022
574 PNEUMOCYSTIS JIROVECII PNEUMONIA 22 0.0022
575 CORONARY ARTERY STENOSIS 11 0.0022
576 ANAPHYLACTOID REACTION 9 0.0022
577 SLEEP DISORDER 154 0.0022
578 GENERALISED OEDEMA 27 0.0022
579 PARADOXICAL DRUG REACTION 8 0.0022
580 UROSEPSIS 20 0.0022
581 LARGE INTESTINE PERFORATION 15 0.0022
582 CONGESTIVE CARDIOMYOPATHY 9 0.0022
583 ELECTROLYTE IMBALANCE 25 0.0021
584 FOETAL GROWTH RESTRICTION 13 0.0021
585 HYPERCALCAEMIA 26 0.0021
586 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
587 ANHEDONIA 55 0.0021
588 HYPOGLYCAEMIA 101 0.0021
589 LOWER RESPIRATORY TRACT INFECTION 94 0.0021
590 SKIN WARM 12 0.0021
591 STAPHYLOCOCCAL INFECTION 68 0.0021
592 HYPOCALCAEMIA 39 0.0021
593 EMBOLISM 17 0.0020
594 DIALYSIS 29 0.0020
595 LUNG INFILTRATION 18 0.0020
596 HEPATIC FUNCTION ABNORMAL 76 0.0020
597 ENCEPHALITIS 14 0.0020
598 DRUG INTOLERANCE 195 0.0020
599 SWELLING 187 0.0020
600 MUSCLE HAEMORRHAGE 8 0.0020
601 HEPATITIS CHOLESTATIC 12 0.0020
602 PERICARDIAL EFFUSION 46 0.0020
603 ANAEMIA 375 0.0020
604 DECUBITUS ULCER 16 0.0020
605 EXPOSURE DURING PREGNANCY 121 0.0019
606 DERMATITIS BULLOUS 14 0.0019
607 MATERNAL EXPOSURE DURING PREGNANCY 172 0.0019
608 PRODUCT ADMINISTRATION ERROR 39 0.0019
609 VENTRICULAR SEPTAL DEFECT 11 0.0019
610 APLASTIC ANAEMIA 10 0.0019
611 LIVE BIRTH 16 0.0019
612 MOUTH HAEMORRHAGE 14 0.0019
613 FACE OEDEMA 32 0.0019
614 CONJUNCTIVITIS 35 0.0019
615 AORTIC VALVE INCOMPETENCE 8 0.0019
616 PULMONARY MASS 28 0.0019
617 LIVER INJURY 46 0.0019
618 FEBRILE NEUTROPENIA 124 0.0019
619 EXTRASYSTOLES 13 0.0019
620 JAUNDICE 50 0.0019
621 LIVER DISORDER 82 0.0018
622 NORMAL NEWBORN 10 0.0018
623 MYOCARDITIS 21 0.0018
624 DRUG RESISTANCE 47 0.0018
625 UPPER RESPIRATORY TRACT INFECTION 84 0.0018
626 HAEMORRHAGE INTRACRANIAL 27 0.0018
627 PULMONARY ARTERIAL HYPERTENSION 26 0.0018
628 TOXIC SKIN ERUPTION 18 0.0018
629 FLUID OVERLOAD 26 0.0018
630 INJECTION SITE EXTRAVASATION 22 0.0018
631 CARDIAC FAILURE 143 0.0018
632 AGRANULOCYTOSIS 33 0.0018
633 CHOLANGITIS 11 0.0018
634 PULMONARY FIBROSIS 34 0.0018
635 INFUSION SITE EXTRAVASATION 11 0.0018
636 MOTOR DYSFUNCTION 18 0.0018
637 OVERDOSE 381 0.0018
638 TRICUSPID VALVE INCOMPETENCE 14 0.0018
639 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
640 ACCIDENTAL OVERDOSE 64 0.0017
641 HYPOKINESIA 25 0.0017
642 CEREBRAL INFARCTION 42 0.0017
643 PRODUCT USE IN UNAPPROVED INDICATION 426 0.0017
644 CYANOSIS 27 0.0017
645 NEUROTOXICITY 30 0.0017
646 ATRIAL FIBRILLATION 166 0.0017
647 ABORTION INDUCED 16 0.0017
648 HAEMATOMA 44 0.0017
649 ABDOMINAL PAIN 395 0.0017
650 LUNG DISORDER 83 0.0017
651 PERITONITIS 35 0.0017
652 TRANSIENT ISCHAEMIC ATTACK 57 0.0017
653 CYTOMEGALOVIRUS INFECTION 28 0.0017
654 PRE-ECLAMPSIA 8 0.0017
655 ACUTE MYOCARDIAL INFARCTION 49 0.0017
656 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
657 HYDROCEPHALUS 9 0.0017
658 CLOSTRIDIUM DIFFICILE INFECTION 36 0.0016
659 INTERNATIONAL NORMALISED RATIO INCREASED 47 0.0016
660 TRANSFUSION 17 0.0016
661 ARRHYTHMIA 76 0.0016
662 OFF LABEL USE 1391 0.0016
663 DRUG LEVEL DECREASED 16 0.0016
664 HYPERTONIA 9 0.0016
665 WRONG DRUG ADMINISTERED 14 0.0016
666 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
667 HYPOPHAGIA 40 0.0016
668 PRODUCT PRESCRIBING ISSUE 34 0.0016
669 ENTEROCOLITIS 9 0.0016
670 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
671 METABOLIC DISORDER 9 0.0015
672 SOMNOLENCE 308 0.0015
673 PANCYTOPENIA 85 0.0015
674 INTESTINAL PERFORATION 17 0.0015
675 BLOOD ALBUMIN DECREASED 12 0.0015
676 MUSCLE RIGIDITY 18 0.0015
677 OVERWEIGHT 8 0.0015
678 LYMPHOPENIA 21 0.0015
679 MOUTH ULCERATION 31 0.0015
680 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
681 PURPURA 13 0.0015
682 PANCREATITIS ACUTE 33 0.0015
683 LEUKOPENIA 73 0.0015
684 CONSTIPATION 317 0.0015
685 GUILLAIN-BARRE SYNDROME 7 0.0014
686 HYPERTENSIVE CRISIS 16 0.0014
687 PROCEDURAL COMPLICATION 11 0.0014
688 NEUROLEPTIC MALIGNANT SYNDROME 17 0.0014
689 RENAL FAILURE CHRONIC 11 0.0014
690 HEPATOMEGALY 14 0.0014
691 INJURY 100 0.0014
692 CHROMATURIA 32 0.0014
693 DUODENAL ULCER 10 0.0014
694 ABDOMINAL TENDERNESS 7 0.0014
695 IRON DEFICIENCY ANAEMIA 13 0.0014
696 POST PROCEDURAL COMPLICATION 27 0.0014
697 C-REACTIVE PROTEIN INCREASED 51 0.0014
698 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 7 0.0014
699 TRANSPLANT REJECTION 11 0.0014
700 BLOOD DISORDER 11 0.0014
701 AGITATION 100 0.0014
702 PERIPHERAL VASCULAR DISORDER 7 0.0014
703 MALNUTRITION 15 0.0013
704 HEPATOCELLULAR INJURY 19 0.0013
705 BRONCHOSPASM 19 0.0013
706 SUBDURAL HAEMATOMA 19 0.0013
707 PARALYSIS 19 0.0013
708 BODY TEMPERATURE INCREASED 27 0.0013
709 GINGIVAL BLEEDING 18 0.0013
710 INGUINAL HERNIA 8 0.0013
711 DERMATITIS ACNEIFORM 8 0.0013
712 PLATELET COUNT DECREASED 140 0.0013
713 HAEMATOCRIT DECREASED 26 0.0013
714 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
715 BLISTER 73 0.0013
716 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
717 DRUG DIVERSION 8 0.0013
718 CONGENITAL ANOMALY 10 0.0013
719 PNEUMONIA 418 0.0013
720 SEIZURE 149 0.0013
721 UNEVALUABLE EVENT 97 0.0013
722 HAEMORRHAGIC STROKE 10 0.0013
723 MYOPATHY 11 0.0013
724 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
725 RESPIRATORY RATE INCREASED 11 0.0012
726 REBOUND EFFECT 14 0.0012
727 HAEMORRHAGE 128 0.0012
728 HYPOMAGNESAEMIA 17 0.0012
729 CARDIOMEGALY 15 0.0012
730 OEDEMA 66 0.0012
731 PNEUMONITIS 33 0.0012
732 CEREBRAL HAEMORRHAGE 43 0.0012
733 HYPERTENSION 253 0.0012
734 MELAENA 26 0.0012
735 HEPATIC ENCEPHALOPATHY 11 0.0012
736 ISCHAEMIC STROKE 21 0.0012
737 CHOLECYSTITIS 14 0.0012
738 ODYNOPHAGIA 7 0.0012
739 LIVER FUNCTION TEST ABNORMAL 34 0.0012
740 GASTROINTESTINAL HAEMORRHAGE 97 0.0012
741 OXYGEN SATURATION DECREASED 65 0.0012
742 SMALL INTESTINAL OBSTRUCTION 14 0.0011
743 RESPIRATORY DISORDER 34 0.0011
744 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
745 DEVICE FAILURE 17 0.0011
746 OEDEMA PERIPHERAL 136 0.0011
747 NEUTROPHIL COUNT DECREASED 45 0.0011
748 LUNG INFECTION 17 0.0011
749 ENTERITIS 7 0.0011
750 HERPES SIMPLEX 7 0.0011
751 LYMPHOCYTE COUNT DECREASED 19 0.0011
752 ATRIAL SEPTAL DEFECT 9 0.0011
753 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
754 ABNORMAL LOSS OF WEIGHT 7 0.0010
755 SPINAL PAIN 12 0.0010
756 PERIPHERAL COLDNESS 14 0.0010
757 HEPATITIS 26 0.0010
758 PYREXIA 347 0.0010
759 POLYNEUROPATHY 12 0.0010
760 GASTRIC ULCER 19 0.0010
761 DIABETIC KETOACIDOSIS 24 0.0010
762 MUSCULOSKELETAL STIFFNESS 87 0.0010
763 LETHARGY 57 0.0010
764 DEEP VEIN THROMBOSIS 64 0.0010
765 MEDICATION ERROR 54 0.0010
766 ERYTHEMA MULTIFORME 9 0.0010
767 HAEMOGLOBIN DECREASED 99 0.0010
768 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
769 ARTERIOSCLEROSIS 9 0.0010
770 PALLOR 26 0.0010
771 VOMITING 448 0.0010
772 DRUG-INDUCED LIVER INJURY 29 0.0009
773 COLITIS 35 0.0009
774 TREATMENT FAILURE 75 0.0009
775 DRUG ERUPTION 16 0.0009
776 APNOEA 7 0.0009
777 MYOSITIS 8 0.0009
778 DISEASE PROGRESSION 105 0.0009
779 WHITE BLOOD CELL COUNT INCREASED 34 0.0009
780 NEUTROPHIL COUNT INCREASED 9 0.0009
781 NEUTROPENIA 119 0.0009
782 HAEMATEMESIS 22 0.0009
783 ANGIOEDEMA 38 0.0009
784 VASCULITIS 10 0.0009
785 CHRONIC KIDNEY DISEASE 65 0.0009
786 BLOOD PRESSURE ABNORMAL 17 0.0009
787 DEVICE RELATED INFECTION 13 0.0008
788 HEMIPLEGIA 7 0.0008
789 CYTOPENIA 10 0.0008
790 PANCREATITIS 43 0.0008
791 IMMUNOSUPPRESSION 7 0.0008
792 HEPATIC ENZYME INCREASED 54 0.0008
793 BONE MARROW FAILURE 16 0.0008
794 FUNGAL INFECTION 26 0.0008
795 THERAPY PARTIAL RESPONDER 12 0.0008
796 HEMIPARESIS 13 0.0008
797 RESPIRATORY ARREST 21 0.0008
798 CONTRAINDICATED PRODUCT ADMINISTERED 23 0.0008
799 GASTROENTERITIS 11 0.0008
800 NO THERAPEUTIC RESPONSE 9 0.0007
801 HAEMATURIA 25 0.0007
802 LOSS OF CONSCIOUSNESS 93 0.0007
803 EPISTAXIS 54 0.0007
804 GASTROINTESTINAL DISORDER 63 0.0007
805 SKIN DISCOLOURATION 32 0.0007
806 GASTRIC HAEMORRHAGE 8 0.0007
807 OBESITY 11 0.0007
808 SKIN DISORDER 23 0.0007
809 ORAL CANDIDIASIS 9 0.0007
810 SARS-COV-2 TEST POSITIVE 9 0.0007
811 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
812 DRUG WITHDRAWAL SYNDROME NEONATAL 10 0.0007
813 PETECHIAE 7 0.0007
814 ASTHMA 75 0.0007
815 INCONTINENCE 7 0.0007
816 ACUTE MYELOID LEUKAEMIA 10 0.0006
817 DEVICE OCCLUSION 9 0.0006
818 DERMATITIS ALLERGIC 8 0.0006
819 DISEASE RECURRENCE 30 0.0006
820 DYSPNOEA 355 0.0006
821 HEART RATE INCREASED 62 0.0006
822 BLOOD CALCIUM DECREASED 7 0.0006
823 CARDIAC FAILURE CONGESTIVE 50 0.0006
824 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
825 PLATELET COUNT INCREASED 8 0.0006
826 MYELOSUPPRESSION 22 0.0006
827 RASH ERYTHEMATOUS 29 0.0006
828 CAESAREAN SECTION 7 0.0006
829 ATAXIA 7 0.0006
830 DRUG DISPENSING ERROR 9 0.0006
831 DRUG TOXICITY 8 0.0006
832 MUSCLE SPASTICITY 7 0.0006
833 HEART RATE DECREASED 20 0.0006
834 TREMOR 94 0.0006
835 BLOOD POTASSIUM DECREASED 17 0.0006
836 ORAL HERPES 11 0.0006
837 APHASIA 17 0.0006
838 INTERSTITIAL LUNG DISEASE 27 0.0006
839 COGNITIVE DISORDER 26 0.0006
840 EPILEPSY 17 0.0006
841 EMOTIONAL DISTRESS 66 0.0005
842 RASH MACULAR 19 0.0005
843 INFLAMMATION 28 0.0005
844 CONFUSIONAL STATE 87 0.0005
845 DEATH 463 0.0005
846 IMMUNODEFICIENCY 8 0.0005
847 CELLULITIS 27 0.0005
848 COVID-19 94 0.0005
849 NAUSEA 410 0.0005
850 CORONARY ARTERY OCCLUSION 7 0.0005
851 URINARY RETENTION 17 0.0005
852 NO ADVERSE EVENT 92 0.0005
853 WHEEZING 30 0.0005
854 COORDINATION ABNORMAL 7 0.0005
855 ABSCESS 8 0.0005
856 MUCOSAL INFLAMMATION 13 0.0005
857 FLATULENCE 28 0.0005
858 RED BLOOD CELL COUNT DECREASED 14 0.0005
859 PRODUCT PREPARATION ERROR 10 0.0005
860 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
861 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
862 INTESTINAL OBSTRUCTION 18 0.0005
863 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
864 GASTROOESOPHAGEAL REFLUX DISEASE 38 0.0005
865 RESTLESSNESS 17 0.0005
866 COMPLETED SUICIDE 38 0.0005
867 EMOTIONAL DISORDER 14 0.0005
868 CONVULSION 25 0.0004
869 HEPATIC STEATOSIS 8 0.0004
870 WITHDRAWAL SYNDROME 18 0.0004
871 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
872 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
873 ANXIETY 114 0.0004
874 PRODUCT USE ISSUE 75 0.0004
875 WHITE BLOOD CELL COUNT DECREASED 43 0.0004
876 HYPERHIDROSIS 51 0.0004
877 CEREBROVASCULAR ACCIDENT 67 0.0004
878 FEEDING DISORDER 8 0.0004
879 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
880 ASTHENIA 145 0.0004
881 DRUG ABUSE 32 0.0004
882 DERMATITIS 8 0.0004
883 SKIN EXFOLIATION 32 0.0004
884 HYPOTHYROIDISM 12 0.0004
885 BLOOD PRESSURE FLUCTUATION 9 0.0004
886 DYSARTHRIA 14 0.0004
887 BLOOD SODIUM DECREASED 7 0.0004
888 SYNCOPE 37 0.0004
889 PRODUCT DISPENSING ERROR 8 0.0004
890 CHILLS 43 0.0004
891 CHOLELITHIASIS 12 0.0004
892 TREATMENT NONCOMPLIANCE 20 0.0004
893 DEHYDRATION 48 0.0004
894 INFECTION 52 0.0004
895 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
896 PRODUCTIVE COUGH 17 0.0004
897 THERAPEUTIC RESPONSE DECREASED 21 0.0003
898 MENTAL DISORDER 15 0.0003
899 BLINDNESS 14 0.0003
900 URTICARIA 57 0.0003
901 MYOCARDIAL INFARCTION 59 0.0003
902 PRODUCT PRESCRIBING ERROR 8 0.0003
903 HYPERSENSITIVITY 62 0.0003
904 BLOOD PRESSURE INCREASED 51 0.0003
905 URINARY TRACT INFECTION 56 0.0003
906 PAIN 201 0.0003
907 DYSPHAGIA 31 0.0003
908 FAECES DISCOLOURED 7 0.0003
909 INFUSION RELATED REACTION 21 0.0003
910 ERYTHEMA 65 0.0003
911 SEDATION 8 0.0003
912 DISORIENTATION 12 0.0003
913 RECTAL HAEMORRHAGE 13 0.0003
914 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 54 0.0003
915 DRUG ADMINISTRATION ERROR 9 0.0003
916 THERAPY CESSATION 15 0.0003
917 SKIN LESION 8 0.0003
918 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
919 INCORRECT DOSE ADMINISTERED 66 0.0003
920 MENTAL IMPAIRMENT 7 0.0003
921 MUSCULAR WEAKNESS 32 0.0003
922 RENAL DISORDER 13 0.0003
923 HALLUCINATION 21 0.0003
924 HAEMATOCHEZIA 15 0.0003
925 EXTRA DOSE ADMINISTERED 11 0.0003
926 RASH 117 0.0003
927 CHEST PAIN 49 0.0003
928 NIGHTMARE 9 0.0003
929 AGGRESSION 13 0.0003
930 SWOLLEN TONGUE 8 0.0003
931 PAIN IN JAW 7 0.0002
932 UNDERDOSE 18 0.0002
933 DIARRHOEA 157 0.0002
934 DISTURBANCE IN ATTENTION 13 0.0002
935 DYSPNOEA EXERTIONAL 9 0.0002
936 COUGH 67 0.0002
937 DEVICE MALFUNCTION 16 0.0002
938 CARDIAC DISORDER 20 0.0002
939 DRUG WITHDRAWAL SYNDROME 18 0.0002
940 PRODUCT DOSE OMISSION ISSUE 60 0.0002
941 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
942 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
943 ECZEMA 10 0.0002
944 SPEECH DISORDER 10 0.0002
945 ABDOMINAL PAIN UPPER 39 0.0002
946 MYALGIA 31 0.0002
947 STOMATITIS 11 0.0002
948 DEPRESSION 41 0.0002
949 FLUID RETENTION 9 0.0002
950 SUICIDAL IDEATION 16 0.0002
951 BACK PAIN 40 0.0002
952 NEUROPATHY PERIPHERAL 16 0.0002
953 HEADACHE 102 0.0002
954 FLUSHING 16 0.0002
955 DEVICE ISSUE 14 0.0002
956 DECREASED APPETITE 36 0.0002
957 DEPRESSED MOOD 8 0.0002
958 FATIGUE 116 0.0001
959 DISCOMFORT 9 0.0001
960 MALAISE 62 0.0001
961 CHEST DISCOMFORT 14 0.0001
962 CONTUSION 13 0.0001
963 IRRITABILITY 8 0.0001
964 DYSPEPSIA 13 0.0001
965 FEELING HOT 8 0.0001
966 DIZZINESS 65 0.0001
967 DRUG DOSE OMISSION BY DEVICE 10 0.0001
968 THERAPY INTERRUPTED 9 0.0001
969 AMNESIA 8 0.0001
970 PALPITATIONS 14 0.0001
971 ADVERSE EVENT 11 0.0001
972 BLOOD GLUCOSE INCREASED 22 0.0001
973 MOBILITY DECREASED 8 0.0001
974 FALL 37 0.0001
975 VISUAL IMPAIRMENT 13 0.0001
976 PRURITUS 39 0.0001
977 PRODUCT QUALITY ISSUE 13 0.0001
978 PARAESTHESIA 15 0.0001
979 BRONCHITIS 7 0.0001
980 PERIPHERAL SWELLING 14 0.0001
981 MUSCLE SPASMS 16 0.0001
982 INSOMNIA 23 0.0001
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
984 ABDOMINAL DISCOMFORT 13 0.0001
985 GAIT DISTURBANCE 13 0.0001
986 HYPOAESTHESIA 10 0.0001
987 ARTHRALGIA 27 0.0001
988 INFLUENZA 7 0.0001
989 WEIGHT DECREASED 17 0.0001
990 PAIN IN EXTREMITY 17 0.0001
991 ALOPECIA 11 0.0001
992 DRUG DEPENDENCE 8 0.0000
993 HOSPITALISATION 7 0.0000
994 WEIGHT INCREASED 9 0.0000
995 NASOPHARYNGITIS 7 0.0000